Search results
Moderna (MRNA) Seeks FDA Nod for Omicron-Based COVID Jab
Zacks via Yahoo Finance· 2 years agoModerna's (MRNA) bivalent COVID-19 booster vaccine, mRNA-1273.222, is designed to target the Omicron...
Moderna (MRNA) Posts Upbeat Data on Bivalent COVID Booster Jab
Zacks via Yahoo Finance· 2 years agoModerna's (MRNA) bivalent COVID booster candidate creates superior neutralizing antibodies compared...
Moderna's (MRNA) Omicron Based Jab gets Approval in Australia
Zacks via Yahoo Finance· 2 years agoModerna (MRNA) receives provisional approval in Australia for its Omicron-containing bivalent...
Moderna Says Omicron Tailored COVID-19 Shots Shows Better Immune Response Than Original Vaccine
Benzinga via Yahoo Finance· 1 year agoModerna Inc (NASDAQ: MRNA) said that data shows its omicron-tailored vaccines, mRNA-1273.214 and...
Moderna's Updated COVID-19 Shot Boosts Omicron Protection
Benzinga via Yahoo Finance· 2 years agoModerna Inc (NASDAQ: MRNA) has announced new clinical data on its omicron-containing bivalent...
Moderna Inks US Supply Contract For Omicron Specific COVID-19 Vaccine Booster Doses
Benzinga via Yahoo Finance· 2 years agoThe U.S. government has secured 66 million doses of Moderna Inc's (NASDAQ: MRNA) COVID-19 vaccine...
Moderna seeks OK from FDA for emergency use of its COVID vaccine in kids 6 months to under 6 years...
USA TODAY via Yahoo News· 2 years agoModerna has submitted a request for emergency use authorization for its COVID-19 vaccine for...
Moderna Climbs On Updated Booster Data, But Analyst Says It Needs A 'Second Act'
Investor's Business Daily· 2 years agoModerna stock gained ground Wednesday after its updated Covid booster generated a strong antibody...
Moderna's Omicron-Adapted Booster Maintains Response Through Three Months
Benzinga via Yahoo Finance· 1 year agoModerna Inc (NASDAQ: MRNA) COVID-19 vaccine booster targeting the BA.1 subvariant of Omicron...
Moderna's Bivalent COVID-19 Booster Shows Antibody Response Against Omicron Subvariants
Benzinga via Yahoo Finance· 2 years agoModerna Inc (NASDAQ: MRNA) has released new clinical data on its bivalent (omicron) COVID booster...
